Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study

被引：0

作者：

Hanania, N. A. ^{[1
]}

Bateman, E. D. ^{[2
]}

Castro, M. ^{[3
]}

Pavord, I. D. ^{[4
]}

Papi, A. ^{[5
]}

FitzGerald, J. M. ^{[6
]}

Maspero, J. F. ^{[7
]}

Katelaris, C. ^{[8
,9
]}

Singh, D. ^{[10
]}

Rice, M. S. ^{[11
]}

Rowe, P. ^{[12
]}

Lu, Y. ^{[13
]}

Amin, N. ^{[13
]}

Staudinger, H. W. ^{[12
]}

Graham, N. M. H. ^{[13
]}

Teper, A. ^{[12
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Univ Cape Town, Cape Town, South Africa

[3] Washington Univ, Sch Med, St Louis, MO USA

[4] Univ Oxford, Oxford, England

[5] Univ Hosp Santa Anna, Ferrara, Italy

[6] Univ British Columbia, Vancouver, BC, Canada

[7] Fdn CIDEA, Buenos Aires, DF, Argentina

[8] Campbelltown Hosp, Sydney, NSW, Australia

[9] Western Sydney Univ, Sydney, NSW, Australia

[10] Univ Manchester, Manchester Univ Fdn Trust NHS Hosp, Manchester, Lancs, England

[11] Sanofi, Cambridge, MA USA

[12] Sanofi, Bridgewater, NJ USA

[13] Regeneron Pharmaceut Inc, Tarrytown, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A2667

引用

页数：2